{"id":8034,"date":"2026-01-09T17:28:22","date_gmt":"2026-01-09T17:28:22","guid":{"rendered":"https:\/\/bioceltix.com\/?p=8034"},"modified":"2026-01-09T17:33:58","modified_gmt":"2026-01-09T17:33:58","slug":"report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market","status":"publish","type":"post","link":"https:\/\/bioceltix.com\/en\/report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market\/","title":{"rendered":"Report No. 3\/2026 Admission and conditional introduction of the Company\u2019s ordinary bearer shares of series O to trading on the WSE Main Market"},"content":{"rendered":"<p><strong>_MACHINE TRANSLATION_<\/strong><\/p>\n<p data-start=\"326\" data-end=\"734\">The Management Board of Bioceltix S.A., with its registered office in Wroc\u0142aw (the \u201cCompany\u201d), hereby announces that today it became aware that on 9 January 2026 the Management Board of the Warsaw Stock Exchange S.A. (the \u201cWSE\u201d) adopted Resolution No. 18\/2026 on the admission and introduction to exchange trading on the WSE Main Market of the Company\u2019s ordinary bearer shares of series O (the \u201cResolution\u201d).<\/p>\n<p data-start=\"736\" data-end=\"1304\">Pursuant to the Resolution, the Management Board of the WSE resolved to: (i) state the admission to exchange trading on the parallel market operated by the WSE of 150,000 (one hundred and fifty thousand) ordinary bearer shares of series O of the Company (the \u201cShares\u201d), and (ii) introduce the Shares to exchange trading on that market as of 14 January 2026, subject to the registration of the Shares by the National Depository for Securities S.A. (Krajowy Depozyt Papier\u00f3w Warto\u015bciowych S.A.) on that date and the designation of the Shares with ISIN code PLBCLTX00019.<\/p>\n<p data-start=\"1306\" data-end=\"1357\"><strong data-start=\"1306\" data-end=\"1357\">Signatures of persons representing the Company:<\/strong><\/p>\n<p data-start=\"1359\" data-end=\"1458\">\u0141ukasz Bzdzion \u2013 President of the Management Board<br data-start=\"1409\" data-end=\"1412\" \/>Pawe\u0142 Wielgus \u2013 Member of the Management Board<\/p>\n<p data-start=\"1359\" data-end=\"1458\"><strong>_MACHINE TRANSLATION_<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>_MACHINE TRANSLATION_ The Management Board of Bioceltix S.A., with its registered office in Wroc\u0142aw (the \u201cCompany\u201d), hereby announces that today it became aware that on 9 January 2026 the Management Board of the Warsaw Stock Exchange S.A. (the \u201cWSE\u201d) adopted Resolution No. 18\/2026 on the admission and introduction to exchange trading on the WSE Main [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[61],"tags":[],"class_list":["post-8034","post","type-post","status-publish","format-standard","hentry","category-espi-2026-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Report No. 3\/2026 Admission and conditional introduction of the Company\u2019s ordinary bearer shares of series O to trading on the WSE Main Market - Bioceltix<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bioceltix.com\/en\/report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Report No. 3\/2026 Admission and conditional introduction of the Company\u2019s ordinary bearer shares of series O to trading on the WSE Main Market - Bioceltix\" \/>\n<meta property=\"og:description\" content=\"_MACHINE TRANSLATION_ The Management Board of Bioceltix S.A., with its registered office in Wroc\u0142aw (the \u201cCompany\u201d), hereby announces that today it became aware that on 9 January 2026 the Management Board of the Warsaw Stock Exchange S.A. (the \u201cWSE\u201d) adopted Resolution No. 18\/2026 on the admission and introduction to exchange trading on the WSE Main [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bioceltix.com\/en\/report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market\/\" \/>\n<meta property=\"og:site_name\" content=\"Bioceltix\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-09T17:28:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-09T17:33:58+00:00\" \/>\n<meta name=\"author\" content=\"Joanna Bzdzion\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Joanna Bzdzion\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/bioceltix.com\\\/en\\\/report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bioceltix.com\\\/en\\\/report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market\\\/\"},\"author\":{\"name\":\"Joanna Bzdzion\",\"@id\":\"https:\\\/\\\/bioceltix.com\\\/#\\\/schema\\\/person\\\/93cd98960be893105050318473122025\"},\"headline\":\"Report No. 3\\\/2026 Admission and conditional introduction of the Company\u2019s ordinary bearer shares of series O to trading on the WSE Main Market\",\"datePublished\":\"2026-01-09T17:28:22+00:00\",\"dateModified\":\"2026-01-09T17:33:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/bioceltix.com\\\/en\\\/report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market\\\/\"},\"wordCount\":206,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/bioceltix.com\\\/#organization\"},\"articleSection\":[\"ESPI 2026\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bioceltix.com\\\/en\\\/report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market\\\/\",\"url\":\"https:\\\/\\\/bioceltix.com\\\/en\\\/report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market\\\/\",\"name\":\"Report No. 3\\\/2026 Admission and conditional introduction of the Company\u2019s ordinary bearer shares of series O to trading on the WSE Main Market - Bioceltix\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bioceltix.com\\\/#website\"},\"datePublished\":\"2026-01-09T17:28:22+00:00\",\"dateModified\":\"2026-01-09T17:33:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bioceltix.com\\\/en\\\/report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/bioceltix.com\\\/en\\\/report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bioceltix.com\\\/en\\\/report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Strona g\u0142\u00f3wna\",\"item\":\"https:\\\/\\\/bioceltix.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Report No. 3\\\/2026 Admission and conditional introduction of the Company\u2019s ordinary bearer shares of series O to trading on the WSE Main Market\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/bioceltix.com\\\/#website\",\"url\":\"https:\\\/\\\/bioceltix.com\\\/\",\"name\":\"Bioceltix\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/bioceltix.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/bioceltix.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/bioceltix.com\\\/#organization\",\"name\":\"Bioceltix\",\"url\":\"https:\\\/\\\/bioceltix.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/bioceltix.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/bioceltix.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/logo-bioceltix.png\",\"contentUrl\":\"https:\\\/\\\/bioceltix.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/logo-bioceltix.png\",\"width\":274,\"height\":73,\"caption\":\"Bioceltix\"},\"image\":{\"@id\":\"https:\\\/\\\/bioceltix.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/bioceltix.com\\\/#\\\/schema\\\/person\\\/93cd98960be893105050318473122025\",\"name\":\"Joanna Bzdzion\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ee564b69e5deab0754d04b3a48e482ac54db2f82922febdfb67174372bd6ae35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ee564b69e5deab0754d04b3a48e482ac54db2f82922febdfb67174372bd6ae35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ee564b69e5deab0754d04b3a48e482ac54db2f82922febdfb67174372bd6ae35?s=96&d=mm&r=g\",\"caption\":\"Joanna Bzdzion\"},\"url\":\"https:\\\/\\\/bioceltix.com\\\/en\\\/author\\\/joanna\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Report No. 3\/2026 Admission and conditional introduction of the Company\u2019s ordinary bearer shares of series O to trading on the WSE Main Market - Bioceltix","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bioceltix.com\/en\/report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market\/","og_locale":"en_US","og_type":"article","og_title":"Report No. 3\/2026 Admission and conditional introduction of the Company\u2019s ordinary bearer shares of series O to trading on the WSE Main Market - Bioceltix","og_description":"_MACHINE TRANSLATION_ The Management Board of Bioceltix S.A., with its registered office in Wroc\u0142aw (the \u201cCompany\u201d), hereby announces that today it became aware that on 9 January 2026 the Management Board of the Warsaw Stock Exchange S.A. (the \u201cWSE\u201d) adopted Resolution No. 18\/2026 on the admission and introduction to exchange trading on the WSE Main [&hellip;]","og_url":"https:\/\/bioceltix.com\/en\/report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market\/","og_site_name":"Bioceltix","article_published_time":"2026-01-09T17:28:22+00:00","article_modified_time":"2026-01-09T17:33:58+00:00","author":"Joanna Bzdzion","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Joanna Bzdzion","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bioceltix.com\/en\/report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market\/#article","isPartOf":{"@id":"https:\/\/bioceltix.com\/en\/report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market\/"},"author":{"name":"Joanna Bzdzion","@id":"https:\/\/bioceltix.com\/#\/schema\/person\/93cd98960be893105050318473122025"},"headline":"Report No. 3\/2026 Admission and conditional introduction of the Company\u2019s ordinary bearer shares of series O to trading on the WSE Main Market","datePublished":"2026-01-09T17:28:22+00:00","dateModified":"2026-01-09T17:33:58+00:00","mainEntityOfPage":{"@id":"https:\/\/bioceltix.com\/en\/report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market\/"},"wordCount":206,"commentCount":0,"publisher":{"@id":"https:\/\/bioceltix.com\/#organization"},"articleSection":["ESPI 2026"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bioceltix.com\/en\/report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market\/","url":"https:\/\/bioceltix.com\/en\/report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market\/","name":"Report No. 3\/2026 Admission and conditional introduction of the Company\u2019s ordinary bearer shares of series O to trading on the WSE Main Market - Bioceltix","isPartOf":{"@id":"https:\/\/bioceltix.com\/#website"},"datePublished":"2026-01-09T17:28:22+00:00","dateModified":"2026-01-09T17:33:58+00:00","breadcrumb":{"@id":"https:\/\/bioceltix.com\/en\/report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bioceltix.com\/en\/report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bioceltix.com\/en\/report-no-3-2026-admission-and-conditional-introduction-of-the-companys-ordinary-bearer-shares-of-series-o-to-trading-on-the-wse-main-market\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Strona g\u0142\u00f3wna","item":"https:\/\/bioceltix.com\/en\/"},{"@type":"ListItem","position":2,"name":"Report No. 3\/2026 Admission and conditional introduction of the Company\u2019s ordinary bearer shares of series O to trading on the WSE Main Market"}]},{"@type":"WebSite","@id":"https:\/\/bioceltix.com\/#website","url":"https:\/\/bioceltix.com\/","name":"Bioceltix","description":"","publisher":{"@id":"https:\/\/bioceltix.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bioceltix.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/bioceltix.com\/#organization","name":"Bioceltix","url":"https:\/\/bioceltix.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bioceltix.com\/#\/schema\/logo\/image\/","url":"https:\/\/bioceltix.com\/wp-content\/uploads\/2025\/05\/logo-bioceltix.png","contentUrl":"https:\/\/bioceltix.com\/wp-content\/uploads\/2025\/05\/logo-bioceltix.png","width":274,"height":73,"caption":"Bioceltix"},"image":{"@id":"https:\/\/bioceltix.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/bioceltix.com\/#\/schema\/person\/93cd98960be893105050318473122025","name":"Joanna Bzdzion","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/ee564b69e5deab0754d04b3a48e482ac54db2f82922febdfb67174372bd6ae35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ee564b69e5deab0754d04b3a48e482ac54db2f82922febdfb67174372bd6ae35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ee564b69e5deab0754d04b3a48e482ac54db2f82922febdfb67174372bd6ae35?s=96&d=mm&r=g","caption":"Joanna Bzdzion"},"url":"https:\/\/bioceltix.com\/en\/author\/joanna\/"}]}},"_links":{"self":[{"href":"https:\/\/bioceltix.com\/en\/wp-json\/wp\/v2\/posts\/8034","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bioceltix.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bioceltix.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bioceltix.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/bioceltix.com\/en\/wp-json\/wp\/v2\/comments?post=8034"}],"version-history":[{"count":1,"href":"https:\/\/bioceltix.com\/en\/wp-json\/wp\/v2\/posts\/8034\/revisions"}],"predecessor-version":[{"id":8035,"href":"https:\/\/bioceltix.com\/en\/wp-json\/wp\/v2\/posts\/8034\/revisions\/8035"}],"wp:attachment":[{"href":"https:\/\/bioceltix.com\/en\/wp-json\/wp\/v2\/media?parent=8034"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bioceltix.com\/en\/wp-json\/wp\/v2\/categories?post=8034"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bioceltix.com\/en\/wp-json\/wp\/v2\/tags?post=8034"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}